Trial Search Results

Molecular Analysis of Breast Cancer

This is a research-based study that is looking at the biologic features of breast tissue, lymph node tissue, or blood in order to study breast cancer development growth, and spread. Through tissue and/or blood samples we hope to gain further knowledge and understanding of how to improve diagnosis and treatment of breast cancer by identifying the molecular markers that predict clinical outcome and response to therapy.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institutes of Health (NIH)

Stanford Investigator(s):


  • Procedure: breast tissue, lymph node tissue or blood


Inclusion Criteria:People eligible for this study include anyone older than 18 years who is
undergoing one of the following procedures: core needle or surgical breast biopsy,
lumpectomy, mastectomy, axillary lymph node surgery, breast reduction surgery, or ductal
lavage or ductoscopy. Patients who have had breast cancer in the past who are currently
free of disease or who have a breast cancer recurrence are also eligible. All patients who
participate must be able to understand and sign the informed consent. Although most
patients will be female, any males undergoing the above procedures are also eligible for
this study. Exclusion Criteria:Any patient who is less than 18 years old, who is unable to
understand the informed consent, or not undergoing the above procedures will be excluded
from this research.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Stefanie Jeffrey